Justyna Rawluk

1.3k total citations
28 papers, 666 citations indexed

About

Justyna Rawluk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Justyna Rawluk has authored 28 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Justyna Rawluk's work include Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Justyna Rawluk is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Justyna Rawluk collaborates with scholars based in Germany, United States and Netherlands. Justyna Rawluk's co-authors include Cornelius F. Waller, Meike Burger, Tanja Nicole Hartmann, Nobutaka Fujii, Thomas J. Kipps, Jan A. Burger, Hirokazu Tamamura, Milena Pantić, Jens Timmer and Clemens Kreutz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Justyna Rawluk

27 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justyna Rawluk Germany 9 260 254 243 243 126 28 666
Serena Matis Italy 17 252 1.0× 180 0.7× 351 1.4× 318 1.3× 215 1.7× 36 767
Charis E. Teh Australia 16 404 1.6× 190 0.7× 428 1.8× 234 1.0× 164 1.3× 34 946
Laurent Vallat France 12 149 0.6× 157 0.6× 264 1.1× 233 1.0× 146 1.2× 27 632
Benjamin L. Lampson United States 15 215 0.8× 205 0.8× 416 1.7× 475 2.0× 348 2.8× 30 942
Johannes Coy Germany 10 225 0.9× 221 0.9× 332 1.4× 490 2.0× 356 2.8× 12 912
S. Öhl Germany 13 179 0.7× 234 0.9× 216 0.9× 264 1.1× 378 3.0× 19 778
Huifeng Niu United States 13 251 1.0× 290 1.1× 362 1.5× 149 0.6× 267 2.1× 17 783
Belinda Austen United Kingdom 13 261 1.0× 318 1.3× 412 1.7× 568 2.3× 339 2.7× 16 956
Michela Frenquelli Italy 13 260 1.0× 88 0.3× 367 1.5× 300 1.2× 173 1.4× 19 720
Simona Tavolaro Italy 16 221 0.8× 141 0.6× 401 1.7× 384 1.6× 282 2.2× 31 820

Countries citing papers authored by Justyna Rawluk

Since Specialization
Citations

This map shows the geographic impact of Justyna Rawluk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justyna Rawluk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justyna Rawluk more than expected).

Fields of papers citing papers by Justyna Rawluk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justyna Rawluk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justyna Rawluk. The network helps show where Justyna Rawluk may publish in the future.

Co-authorship network of co-authors of Justyna Rawluk

This figure shows the co-authorship network connecting the top 25 collaborators of Justyna Rawluk. A scholar is included among the top collaborators of Justyna Rawluk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justyna Rawluk. Justyna Rawluk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rawluk, Justyna, et al.. (2024). Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lung. Scientific Reports. 14(1). 14250–14250. 2 indexed citations
2.
Popp, Ilinca, Rianne D.W. Vaes, Lotte Wieten, et al.. (2023). Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials. Radiotherapy and Oncology. 190. 110048–110048. 7 indexed citations
3.
Bozorgmehr, Farastuk, et al.. (2023). Immune checkpoint inhibitors in non-small cell lung cancer – When should we dare to stop treatment?. Lung Cancer. 184. 107340–107340. 2 indexed citations
4.
Brueckl, Wolfgang M., Martin Reck, Kai Neben, et al.. (2022). Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study. Journal of Geriatric Oncology. 14(1). 101394–101394. 2 indexed citations
5.
Rawluk, Justyna & Cornelius F. Waller. (2021). Medikamentöse Therapie des Oropharynxkarzinoms. HNO. 69(4). 285–297. 1 indexed citations
6.
Brückl, W., Martin Reck, Frank Griesinger, et al.. (2021). Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice. Therapeutic Advances in Medical Oncology. 13. 4277424393–4277424393. 10 indexed citations
7.
Rawluk, Justyna, Annette Schmitt‐Graeff, Federico Simonetta, et al.. (2020). MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors. JCI Insight. 5(6). 64 indexed citations
8.
Troilo, Arianna, Claudia Wehr, Iga Janowska, et al.. (2020). Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency. Blood. 135(17). 1452–1457. 7 indexed citations
9.
Poxleitner, Philipp, Khalid Shoumariyeh, Pit Jacob Voss, et al.. (2020). Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma – a case report and review of the literature. Journal of Stomatology Oral and Maxillofacial Surgery. 121(5). 599–603. 3 indexed citations
10.
Reinmuth, Niels, Michael Bitzer, Barbara Deschler-Baier, et al.. (2019). Nebenwirkungsmanagement in der Immunonkologie : Praktische Aspekte im Management immunvermittelter Nebenwirkungen unter immunonkologischer Therapie. DMW - Deutsche Medizinische Wochenschrift. 144(5). 346–353. 1 indexed citations
11.
Schmid, Severin, Ágnes Csanádi, Nikola Kozhuharov, et al.. (2018). CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer. Anticancer Research. 38(7). 3913–3918. 8 indexed citations
12.
Csanádi, Ágnes, Konrad Aumann, Justyna Rawluk, et al.. (2018). Overexpression of SLC1a5 in lymph node metastases outperforms assessment in the primary as a negative prognosticator in non-small cell lung cancer. Pathology. 50(3). 269–275. 11 indexed citations
13.
Rawluk, Justyna & Cornelius F. Waller. (2018). Gefitinib. Recent results in cancer research. 211. 235–246. 71 indexed citations
14.
Brueckl, Wolfgang M., Eckart Laack, Martin Reck, et al.. (2018). Efficacy of afatinib in the clinical practice: First results of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany. Annals of Oncology. 29. viii524–viii524. 4 indexed citations
15.
16.
Csanádi, Ágnes, Konrad Aumann, Justyna Rawluk, et al.. (2015). Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly. PLoS ONE. 10(5). e0126357–e0126357. 31 indexed citations
17.
Kayser, Gian, Ágnes Csanádi, Claudia Otto, et al.. (2013). Simultaneous Multi-Antibody Staining in Non-Small Cell Lung Cancer Strengthens Diagnostic Accuracy Especially in Small Tissue Samples. PLoS ONE. 8(2). e56333–e56333. 17 indexed citations
18.
19.
Pfeifer, Dietmar, Milena Pantić, Justyna Rawluk, et al.. (2006). Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood. 109(3). 1202–1210. 167 indexed citations
20.
Burger, Meike, Tanja Nicole Hartmann, Justyna Rawluk, et al.. (2005). Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood. 106(5). 1824–1830. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serena Matis Breakdown of academic impact, for papers by Charis E. Teh Breakdown of academic impact, for papers by Laurent Vallat Breakdown of academic impact, for papers by Benjamin L. Lampson Breakdown of academic impact, for papers by Johannes Coy Breakdown of academic impact, for papers by S. Öhl Breakdown of academic impact, for papers by Huifeng Niu Breakdown of academic impact, for papers by Belinda Austen Breakdown of academic impact, for papers by Michela Frenquelli Breakdown of academic impact, for papers by Simona Tavolaro
Rankless by CCL
2026